新易盛（300502.SZ）2024 年年报及 2025 年一季报点评 25Q1 业绩超预期，AI 驱动高端光模块需求高增 2025 年 04 月 24 日 ➢ 事件：4 月 22 日，公司发布 2024 年年报及 2025 年一季报。2024 年全年 实现营收 86.47 亿元，同比增长 179.2%，实现归母净利润 28.38 亿元，同比增 长 312.26%，实现扣非归母净利润 28.30 亿元，同比增长 317.59%。2025 年一 季度来看，单季度实现营收 40.52 亿元，同比增长 264.1%，实现归母净利润 15.73 亿元，同比增长 384.5%，实现扣非归母净利润 15.69 亿元，同比增长 383.10%。 ➢ AI 需求驱动，2024 年及 2025 年一季度业绩持续保持高增长趋势：公司 2024 年和 2025 年一季度营收分别实现同比增长 179.2%和 264.1%，主要受益 于 AI 驱动下游客户算力侧投资持续增长，持续推高高端光模块需求。2024 年营 收按地区拆分，1）国外：2024 年实现营收 68.05 亿元，同比增长 162.3%，营 收占比达 78.7%；2）国内 ...

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance in the coming year [3]. Core Viewpoints - The company achieved a revenue of 797 million yuan in 2024, representing a year-on-year growth of 26.42%. However, the net profit attributable to shareholders decreased by 30.51% to 56 million yuan due to intensified product price competition [1]. - The establishment of the Thailand production base is expected to enhance the company's competitive strength by avoiding tariff impacts and expanding product capacity. The first phase of the Thailand project has commenced production, with an estimated annual revenue of 400 million yuan from the new synthetic vanillin production line [2]. - The company is projected to see significant profit growth in the coming years, with net profits expected to reach 260 million yuan in 2025, 342 million yuan in 2026, and 406 million yuan in 2027, reflecting a recovery from the previous year's decline [3]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of 797 million yuan, with a growth rate of 26.42%. The net profit attributable to shareholders was 56 million yuan, down 30.51% year-on-year. The fourth quarter of 2024 saw revenue of 221 million yuan, a 41.79% increase year-on-year [1]. - The revenue breakdown by business segments for 2024 includes synthetic flavors (85 million yuan), cooling agents (317 million yuan), natural flavors (383 million yuan), and other products (12 million yuan) [1]. Future Projections - Revenue projections for 2025, 2026, and 2027 are 1.78 billion yuan, 2.12 billion yuan, and 2.46 billion yuan, respectively, with growth rates of 123.4%, 19.0%, and 16.2% [4]. - The expected net profit for 2025 is 260 million yuan, with a significant recovery projected for subsequent years [4]. Valuation Metrics - The current price of the stock is 81.99 yuan, with projected price-to-earnings (PE) ratios of 25X for 2025, 19X for 2026, and 16X for 2027 [5][4].

基金转债持仓分析 25Q1 和而不同，标的分化 2025 年 04 月 24 日 ➢ 2025Q1 公募基金转债持仓概览 2025Q1，股票及混合型基金业绩整体亮眼，债券类基金业绩偏弱；指数型 股票及混合债基份额弱增长，主动权益类基金份额微降，纯债型债基份额明显缩 水。公募基金同步增持股债主流资产，25Q1 持债市值环比增长 4.36%至 19.70 万亿元，债券仓位占比 58.19%，环比增长 4pct。 伴随转债赎回潮，2025Q1 公募基金持有转债市值环比继续微降，但转债参 与度继续上升。全市场持有转债的公募基金数量在 25Q1 末大幅增至 2350 只， 与 23Q3 持平；持有转债市值占存续转债余额衡量的比例环比提升 1.25pct 至 40.83%，由转债价格上涨和转债市场缩量共同驱动。 2025Q1，二级债基继续减仓转债，转债基金和一级债基持有转债市值创历 史新高。2025Q1二级债基持有转债市值环比下降4.77%至940亿元，为2021Q4 以来最低水平；一级债基持有转债市值微增 4.02%达 665 亿元，创历史新高；转 债基金持有转债市值增长 4%至 897.37 亿元，转债仓位占比上升 ...

Investment Rating - The report maintains a "Recommended" rating for the company [1][4]. Core Insights - The company achieved a revenue of 620 million yuan in Q1 2025, representing a year-on-year growth of 51.36% and a quarter-on-quarter growth of 2.86%. The net profit attributable to the parent company was 92 million yuan, with a year-on-year increase of 86.51% and a quarter-on-quarter increase of 481.13% [1]. - For the full year 2024, the company reported a revenue of 2.288 billion yuan, an increase of 36.76% year-on-year, and a net profit of 167 million yuan, which is a significant year-on-year growth of 626.15% [2]. - The company is focusing on the smart application market, leveraging advancements in AI technology to drive growth in various sectors including smart automotive electronics, industrial control, and consumer electronics [2][4]. Financial Performance Summary - The company’s revenue and profit are expected to continue growing, with projected net profits of 322 million yuan, 494 million yuan, and 667 million yuan for 2025, 2026, and 2027 respectively, corresponding to PE ratios of 96, 63, and 47 [4][5]. - The revenue growth rates are projected at 30.1% for 2025, 26.8% for 2026, and 22.1% for 2027 [5]. - The company has successfully developed new AI algorithms and products, enhancing its competitive position in the market [3][4]. Product and Market Development - The company has introduced new products such as the MR536 chip for robotics and the T536 chip for industrial control, which integrate advanced NPU capabilities [3]. - Collaborations with major industry players like Xiaomi, Tencent, and Alibaba are ongoing, focusing on AI applications in voice and vision [4]. Future Outlook - The company is committed to its "SoC+" and "Smart Big Video" strategies, aiming for continuous innovation and market expansion [2][4]. - The report anticipates sustained performance growth driven by ongoing product iterations and recovery in downstream demand [4].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [6]. Core Views - The company experienced significant revenue decline in 2024, with total revenue of 8.207 billion yuan, a year-on-year decrease of 31.25%. The net profit attributable to shareholders was -308 million yuan, down 160.36% year-on-year [1][5]. - In Q1 2025, the company reported a revenue of 2.098 billion yuan, a slight decrease of 2.09% year-on-year, but a net profit of 65 million yuan, representing a 69.24% increase year-on-year [1]. - The company’s four major business segments are showing collaborative growth, particularly in lithium hexafluorophosphate, which saw sales of 4.33 tons and revenue of 2.593 billion yuan in 2024, accounting for 31.59% of total revenue [3]. Summary by Sections Financial Performance - In Q4 2024, the company reported a revenue of 1.331 billion yuan, a decrease of 57.78% year-on-year, and a net profit of -333 million yuan, turning from profit to loss compared to Q4 2023 [2]. - The gross margin for Q4 2024 was 10.88%, a decrease of 0.23 percentage points year-on-year, while the net margin was -38.65%, down 40 percentage points year-on-year [2]. Business Segments - The revenue breakdown for 2024 shows that fluorine-based new materials generated 2.693 billion yuan (32.81% of total revenue), electronic information materials contributed 935 million yuan (11.39%), and new energy batteries accounted for 1.611 billion yuan (19.63%) [3]. - The company has established a clear capacity layout, with an annual production capacity of 60,000 tons of electronic-grade hydrofluoric acid and ongoing expansion in various fields [3]. Future Outlook - The company is projected to achieve revenues of 10.742 billion yuan, 13.408 billion yuan, and 16.190 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 30.9%, 24.8%, and 20.8% [4][5]. - The net profit attributable to shareholders is expected to recover to 290 million yuan in 2025, with significant growth anticipated in subsequent years [4][5].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating an expected price increase of over 15% relative to the benchmark index within the next 12 months [4][11]. Core Views - The company has shown resilience in the face of short-term fluctuations, with strong potential for growth driven by new product releases, particularly PDO [1][4]. - The company is recognized as a leader in synthetic biology, with its core business in alanine and valine anaerobic processes leading the industry [4]. Financial Performance Summary - In 2024, the company achieved revenue of 2.178 billion yuan, a year-on-year increase of 12.37%. However, the net profit attributable to shareholders decreased by 57.80% to 190 million yuan [1][5]. - For Q4 2024, revenue was 639 million yuan, reflecting a year-on-year growth of 11.29% and a quarter-on-quarter increase of 22.21%. The net profit for this quarter was 20 million yuan, down 84.80% year-on-year [1][5]. - In Q1 2025, revenue reached 687 million yuan, a significant year-on-year increase of 37.20%, while net profit decreased by 40.98% to 51 million yuan [1][5]. Business Segment Performance - In 2024, the amino acids segment generated revenue of 1.509 billion yuan, with a growth of 3.01%. The vitamin segment saw a decline of 5.04% to 207 million yuan, while other products surged by 318.70% to 89 million yuan [2]. - The gross profit margins for these segments were 30.00%, 20.77%, and 28.58%, respectively, with notable declines in margins due to increased operational costs and competitive pricing pressures [2]. Product and Market Outlook - Valine prices showed signs of recovery in 2025 after a significant decline in 2024, with an average price of 14,653 yuan per ton, a 36.66% decrease year-on-year [3]. - The company has made key breakthroughs in new products such as 1,3-propanediol (PDO), which is expected to enhance its product portfolio and market reach [3]. Earnings Forecast - The company is projected to achieve net profits of 301 million yuan, 406 million yuan, and 545 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding EPS of 1.20 yuan, 1.63 yuan, and 2.18 yuan [4][5]. - The expected PE ratios for these years are 23, 17, and 13, respectively, indicating a favorable valuation trend [4][5].

燕京啤酒（000729.SZ）2024 年年报点评 核心财务指标持续改善，改革逻辑加速兑现 2025 年 04 月 24 日 ➢ 事件：2025 年 4 月 21 日，公司发布 2024 年年报。2024 年公司实现总营 收 / 归 母 净 利 润 / 扣 非 归 母 净 利 润 146.67/10.56/10.41 亿元， 分 别 同 比 +3.20%/+63.74%/+108.03%。经测算，24Q4 公司实现总营收/归母净利润/扣 非归母净利润 18.21/-2.32/-2.21 亿元，营收同比+1.32%，归母口径利润减亏 0.79 亿元，扣非归母口径减亏 1.45 亿元。 ➢ 销量跑赢大盘，U8 势能维持。24 年公司啤酒营收同比增 1.0%，其中销量 同比+1.6%至 400 万千升（同期我国规上啤酒企业总产量同比-0.6%），销量跑 赢大盘。结构端看，中高档产品营收同比+2.2%至 88.7 亿元，占啤酒营收比重 同比+0.7pct，其中 U8 销量同比+31%至 70 万千升，维持良好势能。24 年吨 价同比微降 0.6%，我们预计与 24Q4 货折兑付节奏有关。其他业务收入合计同 比+29% ...

Investment Rating - The report maintains a "Recommended" rating for the company, with a target price of 16.34 CNY [7]. Core Views - The company reported a revenue of 3.12 billion CNY in Q1 2025, representing a year-on-year increase of 14.5% but a quarter-on-quarter decrease of 33.4%. The net profit attributable to shareholders was 1.14 billion CNY, up 22.5% year-on-year but down 24.7% quarter-on-quarter [2]. - The lithium carbonate segment saw a decline in both volume and price, with production and sales of 0.85 and 0.81 million tons respectively, down 2.1% and 17.9% year-on-year. The average market price for lithium carbonate was 75,000 CNY per ton, down 26.0% year-on-year [3]. - In contrast, the potassium chloride segment experienced a significant price increase, with production and sales of 965,000 and 891,000 tons respectively. The average selling price for potassium fertilizer was approximately 2,750 CNY per ton, up 2.4% year-on-year [3]. - The company has successfully reduced its total expenses, with a significant decrease in sales and management costs, leading to a low expense ratio [3]. Summary by Sections Financial Performance - In Q1 2025, the company achieved a total revenue of 3.12 billion CNY, with a net profit of 1.14 billion CNY, reflecting a year-on-year growth of 22.5% [2]. - The company’s total expenses were 160 million CNY, a decrease of 60.5% quarter-on-quarter, with sales expenses down 72.4% [3]. Production and Pricing - Lithium carbonate production and sales volumes decreased, while potassium chloride prices increased significantly, contributing positively to the company's performance [3]. - The company is expanding its low-cost lithium carbonate production capacity, aiming to reach a total capacity of 80,000 tons by the end of the year [4]. Strategic Development - The company is actively integrating into China's "Three-Step" development strategy for salt lakes, targeting significant increases in potassium and lithium production by 2030 [4]. - The company holds the leading position in domestic potassium chloride production with a capacity of 5 million tons, benefiting from favorable market conditions [4]. Profit Forecast - The company forecasts net profits of 5.2 billion CNY, 6.4 billion CNY, and 7.1 billion CNY for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 17, 14, and 12 [5][6].

Investment Rating - The report maintains a "Recommended" rating for the company, considering its leading position in the domestic high-tech electronic components sector [6][8]. Core Views - The company reported a revenue of 5.22 billion yuan for 2024, a year-on-year decrease of 33.0%, and a net profit of 970 million yuan, down 63.8% year-on-year. The first quarter of 2025 showed a revenue of 910 million yuan, down 10.4% year-on-year, and a net profit of 59 million yuan, down 42.6% year-on-year. The performance aligns with expectations despite significant challenges in the market [3]. - The company faces pressure from cyclical market fluctuations and price reductions affecting profitability. The gross margin for 2024 decreased by 9.6 percentage points to 49.7%, and the net margin fell by 15.8 percentage points to 18.6% due to intensified competition and changes in procurement and technology [3][4]. - The company expects a revenue of 5.7 billion yuan for 2025, representing a year-on-year growth of 9.2%, and a total profit of 1.145 billion yuan, up 3.1% year-on-year [4]. Summary by Sections Financial Performance - In 2024, the company experienced a significant decline in revenue and profit across its subsidiaries, with notable decreases in revenue and net profit for its main business units [4]. - The company’s operating cash flow improved, with net cash flow from operating activities reaching 1.6 billion yuan in 2024, compared to 1.23 billion yuan in 2023 [5]. Revenue and Profit Forecast - The forecast for 2025 to 2027 indicates a gradual recovery, with expected net profits of 1.134 billion yuan, 1.371 billion yuan, and 1.6 billion yuan respectively, alongside corresponding PE ratios of 27x, 22x, and 19x [6][7]. Market Position and Strategy - The company is positioned as a core supplier in the high-tech electronic components field, leveraging its brand value matrix and capabilities in various emerging sectors such as commercial aerospace and new energy vehicles [6].

Investment Rating - The report maintains a "Recommended" rating for the company, considering its continuous improvement in profitability and increasing self-supply rate of graphite [6][8]. Core Views - The company achieved a revenue of 5.581 billion yuan in 2024, representing a year-on-year growth of 13.72%, and a net profit attributable to shareholders of 303 million yuan, which is a significant increase of 626.56% year-on-year [3][4]. - In Q1 2025, the company reported a revenue of 1.598 billion yuan, up 49.92% year-on-year, and a net profit of 134 million yuan, reflecting a growth of 465.80% year-on-year [3]. - The lithium battery anode business saw a substantial increase in shipments, with a total of 225,800 tons shipped in 2024, marking a year-on-year growth of 55.66% [5]. Financial Performance Summary - **2024 Financials**: Revenue reached 5.581 billion yuan, with a net profit of 303 million yuan. The gross margin was 20.87% [7][13]. - **2025-2027 Projections**: Expected revenues of 6.918 billion yuan, 9.243 billion yuan, and 11.650 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 655 million yuan, 864 million yuan, and 1.182 billion yuan [6][7]. - **Profitability Metrics**: The projected PE ratios for 2025, 2026, and 2027 are 16, 12, and 9 respectively, indicating a favorable valuation trend [6][7]. Business Development - The company is actively expanding its overseas customer base, establishing stable partnerships with major domestic and international battery manufacturers, including CATL and BYD [6]. - The company is progressing with the construction of its integrated anode material production project in Yunnan and planning a production base in Morocco [5].